Concepedia

Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method

Peter Schubert, Brankica Culibrk, Simrath Karwal, Katherine Serrano, E.J. Levin, Daniel Bu, Varsha Bhakta, William P. Sheffield, Raymond P. Goodrich, Dana V. Devine

Transfusion · 2014 · 40 citations · 28 references

DOI

Abstract

Treatment of WB with riboflavin and UV before production of components by the BC method shows a negative impact on all three blood components. PLT units produced from PI-treated WB exhibited less damage compared to PLT component treatment.

References

28

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time

Heather F. Pidcoke, Steve J. McFaul, Anand K. Ramasubramanian et al. · Transfusion · 2013 · 212 citations

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

Jean‐Pierre Cazenave, Gilles Folléa, Laurent Bardiaux et al. · Transfusion · 2010 · 167 citations

A comparative study of common techniques used to measure haemolysis in stored red cell concentrates

Vanessa Han, Katherine Serrano, Dana V. Devine · Vox Sanguinis · 2009 · 135 citations

Implementation of buffy coat platelet component production: comparison to platelet‐rich plasma platelet production

E.J. Levin, Brankica Culibrk, Maria I.C. Gyöngyössy‐Issa et al. · Transfusion · 2008 · 100 citations

The cost‐effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model

Brian Custer, Maria Agapova, Rebecca Havlir Martinez · Transfusion · 2010 · 82 citations

, , +24